OT-81

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameOT-81
Drug Alias Nameadenosine deaminase replacement therapy (St. Georges University of London)OT-81
ClassificationBiologics > Protein drugs > Enzyme > Recombinant enzymeBiologics > Protein drugs > Recombinant protein > Recombinant enzymeCell and gene therapy > Cell therapy > Somatic cell > Erythrocyte therapy
Mechanisms of ActionAdenosine deaminase stimulants
TargetsAdenosine deaminase
Therapy Area/IndicationsSevere Combined Immunodeficiency
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerlandUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSt Georges University of London
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesOrphan Technologies LtdSt Georges University of London
Active IndicationsN/A
Inactive IndicationsSevere Combined Immunodeficiency

Other Information

ATC CodeN/A
Related LinksN/A